You've built something real. We build the company around it.
If your research has a defensible edge and no route to market, that is the exact problem Quascade exists to solve. You keep doing the science. We do the commercial work — IP position, business model, capital and customers.
Four things, and none of them is a business plan.
We are agnostic about geography, institution and stage. We are not agnostic about whether the science holds up.
A defensible technical edge
Something that is genuinely hard to replicate — a method, a device, a material, a result. Published validation, a patent position or reproducible data all count. A promising idea without evidence does not.
A line of sight to a real buyer
We don't need you to have found the customer. We do need to be able to imagine one — an industry with a problem your work addresses better than what exists today.
Clean or clarifiable IP
Ownership needs to be resolvable. University-held, jointly owned, grant-encumbered — all workable. Contested or already exclusively licensed elsewhere is usually not.
A researcher who wants this to exist
You don't have to leave your post or become a CEO. You do have to want the work to reach the world, and be willing to stay involved technically while we build.
Everything between a result and a company.
We do this
The commercial half of the work.
- IP strategy — filing, freedom-to-operate, licensing structure with your institution
- Commercial architecture — who buys this, at what price, through what channel
- Capital — funding the build, then raising against a real company
- Customer access — the enterprise relationships our advisory work already opens
- Operating team — the commercial hires you shouldn't have to make
You keep this
Your work, your name, your position.
- Scientific direction — the technical roadmap stays yours
- Equity — a meaningful founding stake in whatever we build
- Your academic post — most of our researchers never leave it
- Publication rights — negotiated up front, not fought over later
- The right to walk — if the evaluation says no, you lose nothing
From first email to a company, in four stages.
Roughly six to nine months, though the first two stages move fast and cost you nothing.
First conversation
You send us the work — a paper, a patent, a deck, or just an email describing it. We respond either way, usually within two weeks.
Technical and market review
We assess the science with external reviewers and size the commercial opportunity. No cost to you, no exclusivity asked for.
Structuring
Licensing terms with your institution, founding equity, scope of the build and the capital required. Everything on paper before work starts.
Build and spin out
We assemble the team, land the first customers and raise the round. The company leaves the studio as a standalone business.
When we're not the right partner.
We would rather tell you quickly than waste six months of your time.
- The result isn't reproducible yet. We are not a research funder. If the science still needs proving, a grant is a better instrument than a venture studio.
- You want a licensing fee and no involvement. Technology transfer offices do this well. We build companies, which needs the inventor engaged.
- The market is a decade out with no interim revenue. Beautiful science, wrong vehicle. We look for a commercial path inside this decade.
- You already have a company and a round. Then you don't need a studio — though we may still be useful as a commercial partner.
Send us the work.
A paper, a patent number, a link, or three paragraphs describing what you've built. We read everything and we reply either way.